Table 1 Clinico-pathological variables of the cohort.
From: Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing
Clinicopathological parameter | (N = 97) |
|---|---|
Median age (in years) | 48 |
Tumor (T) stage | |
 T1 | 11 (11%) |
 T2 | 49 (50%) |
 T3 | 13 (14%) |
 T4 | 24 (25%) |
Node (N) status | |
 N0 | 41 (42%) |
 N+ | 56 (58%) |
Metastasis (M) status | |
 Mx | 26 (27%) |
 M0 | 55 (56%) |
 M1 | 16 (17%) |
Hormone receptor (HR) status | |
 HR+ | 50 (52%) |
 HR− | 47 (48%) |
 Her2 status | |
 Her2+ | 38 (39%) |
 Her2− | 59 (61%) |
Molecular subtype | |
 HR+/HER2− | 30 (31%) |
 HR+/HER2+ | 20 (21%) |
 HR−/HER2+ | 18 (18%) |
 HR−/HER2− | 29 (30%) |
